BusinessUpdated 16 min ago
Lupin launches biosimilar Ranibizumab through Sandoz in Europe except Germany

Ranluspec approved by European Commission in vial and pre-filled syringe forms for retinal disease treatment
Continue reading on BusinessLine
Read full story Hello Headlines links you to the original publisher for the full story.


